These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7748457)

  • 1. Potential bioreductively activated hypoxia probes and post-irradiation radiosensitizers related to NITP.
    Mehta LK; Monney H; Parrick J; Hodgkiss RJ
    Anticancer Drug Des; 1995 Apr; 10(3):227-41. PubMed ID: 7748457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and binding of the bioreductive probe for hypoxia, NITP: effect of route of administration.
    Hodgkiss RJ; Stratford MR; Dennis MF; Hill SA
    Br J Cancer; 1995 Dec; 72(6):1462-8. PubMed ID: 8519660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
    Webster L; Hodgkiss RJ; Wilson GD
    Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-specific inhibition of recovery from radiation damage by a novel 2-nitroimidazole with a theophylline side chain.
    Hodgkiss RJ; Kelleher E; Parrick J
    Int J Radiat Biol; 1992 Jun; 61(6):797-803. PubMed ID: 1351530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bioreductive markers for tumour hypoxia.
    Hodgkiss RJ; Webster L; Wilson GD
    Acta Oncol; 1995; 34(3):351-5. PubMed ID: 7779422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational exchange in pimonidazole--a hypoxia marker.
    Gabellieri C; Eykyn TR; Leach MO
    Magn Reson Chem; 2007 Aug; 45(8):621-3. PubMed ID: 17559161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel fluorinated hypoxia-targeted compounds as Non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS).
    Papadopoulou MV; Ji M; Bloomer WD
    Anticancer Res; 2006; 26(5A):3253-8. PubMed ID: 17094437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography.
    Aboagye EO; Kelson AB; Tracy M; Workman P
    Anticancer Drug Des; 1998 Sep; 13(6):703-30. PubMed ID: 9755726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
    Papadopoulou MV; Pouremad R; Bloomer WD; Wyrwicz A
    Anticancer Res; 2006; 26(5A):3259-63. PubMed ID: 17094438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
    Papadopoulou MV; Rosenzweig HS; Bloomer WD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.
    Emami S; Kumar P; Yang J; Kresolic Z; Paproski R; Cass C; McEwan AJ; Wiebe LI
    J Pharm Pharm Sci; 2007; 10(2):237-45. PubMed ID: 17706182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro.
    Naylor MA; Threadgill MD; Showalter HD; Stratford IJ; Stephens MA; Fielden EM; Adams GE
    Drug Des Discov; 1993; 10(3):249-55. PubMed ID: 8268395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two techniques for detecting tumour hypoxia: a fluorescent immunochemical method and an in vitro colony assay.
    Stern S; Hodgkiss RJ; Guichard M
    Radiother Oncol; 1996 May; 39(2):129-35. PubMed ID: 8735480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroimidazole-based "extruded mustards' designed as reductively activated hypoxia-selective cytotoxins.
    Hay MP; Denny WA; Wilson WR
    Anticancer Drug Des; 1996 Jul; 11(5):383-402. PubMed ID: 8765531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities.
    Cowan DS; Matejovic JF; Wardman P; McClelland RA; Rauth AM
    Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers.
    Naylor MA; Stephens MA; Stratford IJ; Keohane A; O'Neill P; Threadgill MD; Webb P; Fielden EM; Adams GE
    Anticancer Drug Des; 1991 Jul; 6(3):151-67. PubMed ID: 1872946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of nonproliferating but viable hypoxic tumor cells in vivo.
    Durand RE; Raleigh JA
    Cancer Res; 1998 Aug; 58(16):3547-50. PubMed ID: 9721858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers.
    Ramalho TC; Bühl M
    Magn Reson Chem; 2005 Feb; 43(2):139-46. PubMed ID: 15558660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
    Rijken PF; Bernsen HJ; Peters JP; Hodgkiss RJ; Raleigh JA; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):571-82. PubMed ID: 10974478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.